Cargando…
Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model
Antibody-mediated rejection (AMR) represents a major cause of allograft dysfunction and results in allograft failure in solid organ transplantation. Cyclic helix B peptide (CHBP) is a novel erythropoietin-derived peptide that ameliorated renal allograft rejection in a renal transplantation model. Ho...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149941/ https://www.ncbi.nlm.nih.gov/pubmed/34054874 http://dx.doi.org/10.3389/fimmu.2021.682749 |
_version_ | 1783698056536915968 |
---|---|
author | Zheng, Long Wang, Xuanchuan Hu, Linkun Gao, Wenjun Zhang, Weitao Zhang, Xuepeng Hu, Chao Rong, Ruiming Yang, Cheng Zhu, Dong |
author_facet | Zheng, Long Wang, Xuanchuan Hu, Linkun Gao, Wenjun Zhang, Weitao Zhang, Xuepeng Hu, Chao Rong, Ruiming Yang, Cheng Zhu, Dong |
author_sort | Zheng, Long |
collection | PubMed |
description | Antibody-mediated rejection (AMR) represents a major cause of allograft dysfunction and results in allograft failure in solid organ transplantation. Cyclic helix B peptide (CHBP) is a novel erythropoietin-derived peptide that ameliorated renal allograft rejection in a renal transplantation model. However, its effect on AMR remains unknown. This study aimed to investigate the effect of CHBP on AMR using a secondary allogeneic skin transplantation model, which was created by transplanting skin from BALB/c mice to C57BL/6 mice with or without CHBP treatment. A secondary syngeneic skin transplantation model, involving transplantation from C57BL/6 mice to C57BL/6 mice, was also created to act as a control. Skin graft rejection, CD19(+) B cell infiltration in the skin allograft, the percentages of splenic plasma cells, germinal center (GC) B cells, and Tfh cells, the serum levels of donor specific antibodies (DSAs), and NF-κB signaling in splenocytes were analyzed. Skin allograft survival was significantly prolonged in the CHBP group compared to the allogeneic group. CHBP treatment also significantly reduced the CD19(+) B cell infiltration in the skin allograft, decreased the percentages of splenic plasma cells, GC B cells, and Tfh cells, and ameliorated the increase in the serum DSA level. At a molecular level, CHBP downregulated P100, RelB, and P52 in splenocytes. CHBP prolonged skin allograft survival by inhibiting AMR, which may be mediated by inhibition of NF-κB signaling to suppress B cell immune responses, thereby decreasing the DSA level. |
format | Online Article Text |
id | pubmed-8149941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81499412021-05-27 Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model Zheng, Long Wang, Xuanchuan Hu, Linkun Gao, Wenjun Zhang, Weitao Zhang, Xuepeng Hu, Chao Rong, Ruiming Yang, Cheng Zhu, Dong Front Immunol Immunology Antibody-mediated rejection (AMR) represents a major cause of allograft dysfunction and results in allograft failure in solid organ transplantation. Cyclic helix B peptide (CHBP) is a novel erythropoietin-derived peptide that ameliorated renal allograft rejection in a renal transplantation model. However, its effect on AMR remains unknown. This study aimed to investigate the effect of CHBP on AMR using a secondary allogeneic skin transplantation model, which was created by transplanting skin from BALB/c mice to C57BL/6 mice with or without CHBP treatment. A secondary syngeneic skin transplantation model, involving transplantation from C57BL/6 mice to C57BL/6 mice, was also created to act as a control. Skin graft rejection, CD19(+) B cell infiltration in the skin allograft, the percentages of splenic plasma cells, germinal center (GC) B cells, and Tfh cells, the serum levels of donor specific antibodies (DSAs), and NF-κB signaling in splenocytes were analyzed. Skin allograft survival was significantly prolonged in the CHBP group compared to the allogeneic group. CHBP treatment also significantly reduced the CD19(+) B cell infiltration in the skin allograft, decreased the percentages of splenic plasma cells, GC B cells, and Tfh cells, and ameliorated the increase in the serum DSA level. At a molecular level, CHBP downregulated P100, RelB, and P52 in splenocytes. CHBP prolonged skin allograft survival by inhibiting AMR, which may be mediated by inhibition of NF-κB signaling to suppress B cell immune responses, thereby decreasing the DSA level. Frontiers Media S.A. 2021-05-12 /pmc/articles/PMC8149941/ /pubmed/34054874 http://dx.doi.org/10.3389/fimmu.2021.682749 Text en Copyright © 2021 Zheng, Wang, Hu, Gao, Zhang, Zhang, Hu, Rong, Yang and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zheng, Long Wang, Xuanchuan Hu, Linkun Gao, Wenjun Zhang, Weitao Zhang, Xuepeng Hu, Chao Rong, Ruiming Yang, Cheng Zhu, Dong Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model |
title | Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model |
title_full | Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model |
title_fullStr | Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model |
title_full_unstemmed | Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model |
title_short | Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model |
title_sort | cyclic helix b peptide prolongs skin allograft survival via inhibition of b cell immune responses in a murine model |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149941/ https://www.ncbi.nlm.nih.gov/pubmed/34054874 http://dx.doi.org/10.3389/fimmu.2021.682749 |
work_keys_str_mv | AT zhenglong cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT wangxuanchuan cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT hulinkun cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT gaowenjun cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT zhangweitao cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT zhangxuepeng cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT huchao cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT rongruiming cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT yangcheng cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel AT zhudong cyclichelixbpeptideprolongsskinallograftsurvivalviainhibitionofbcellimmuneresponsesinamurinemodel |